Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
ceo
2
×
commissioner
detroit blog main
detroit top stories
fda
2
×
gene editing
ipo
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
scott gottlieb
seattle blog main
seattle top stories
shutdown
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
ac immune
acquisition
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
alliances
What
bio
2
×
medicine
roundup
big
biopharma
bosley's
bosley’s
bridge
bucks
car
cas
celgene
ceo
colleagues
crime
crispr
departure
editas
exit
exome
government
guiding
health
hundreds
industry
katrine
moves
personnel
policy
published
ready
sf
stories
surprising
tales
week
Language
Current search:
bio
×
fda
×
ceo
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More